247 related articles for article (PubMed ID: 20406101)
1. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.
Kanaan Z; Qadan M; Eichenberger MR; Galandiuk S
Genet Test Mol Biomarkers; 2010 Jun; 14(3):347-53. PubMed ID: 20406101
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
He Y; Chen L; Chen K; Sun Y
Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation.
Olaru AV; Selaru FM; Mori Y; Vazquez C; David S; Paun B; Cheng Y; Jin Z; Yang J; Agarwal R; Abraham JM; Dassopoulos T; Harris M; Bayless TM; Kwon J; Harpaz N; Livak F; Meltzer SJ
Inflamm Bowel Dis; 2011 Jan; 17(1):221-31. PubMed ID: 20848542
[TBL] [Abstract][Full Text] [Related]
5. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
6. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
Gui X; Iacucci M; Ghosh S
Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
Lynch HT; Brand RE; Locker GY
Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
[TBL] [Abstract][Full Text] [Related]
9. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease.
Olaru AV; Yamanaka S; Vazquez C; Mori Y; Cheng Y; Abraham JM; Bayless TM; Harpaz N; Selaru FM; Meltzer SJ
Inflamm Bowel Dis; 2013 Mar; 19(3):471-80. PubMed ID: 23399735
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.
Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N
J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850
[TBL] [Abstract][Full Text] [Related]
14. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
15. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
Zhang H; Yang W; Yan J; Zhou K; Wan B; Shi P; Chen Y; He S; Li D
Int J Oncol; 2018 Sep; 53(3):1118-1128. PubMed ID: 30015842
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of ulcerative colitis-associated neoplastic progression.
Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
[TBL] [Abstract][Full Text] [Related]
17. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
[TBL] [Abstract][Full Text] [Related]
18. Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.
Wang W; Ji G; Xiao X; Chen X; Qin WW; Yang F; Li YF; Fan LN; Xi WJ; Huo Y; Wen WH; Yang AG; Wang T
Oncotarget; 2016 Oct; 7(42):68674-68687. PubMed ID: 27626692
[TBL] [Abstract][Full Text] [Related]
19. WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance.
Claessen MM; Schipper ME; Oldenburg B; Siersema PD; Offerhaus GJ; Vleggaar FP
Cell Oncol; 2010 Jan; 32(4):303-10. PubMed ID: 20208143
[TBL] [Abstract][Full Text] [Related]
20. Genes regulated by Nkx2-3 in sporadic and inflammatory bowel disease-associated colorectal cancer cell lines.
Yu W; Lin Z; Pastor DM; Hegarty JP; Chen X; Kelly AA; Wang Y; Poritz LS; Koltun WA
Dig Dis Sci; 2010 Nov; 55(11):3171-80. PubMed ID: 20165982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
